Biotechnology News and Research

RSS

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that it has acted on a request to provide opaganib treatment on an outpatient basis under compassionate use exemption for several Swiss patients suffering from COVID-19 pneumonia.

22 Mar 2021

New book explains the functional aspects of melanogenesis and related disorders

The Vertebrate Pigmentary System: From pigment cells to disorders provides readers with fundamental knowledge of the structural and functional aspects of vertebrate pigment cells - melanophores and melanocytes - from their origin to different stages of development to related diseases.

22 Mar 2021

Novel form of polymerized estrogen could provide neuroprotection

A novel form of polymerized estrogen developed at Rensselaer Polytechnic Institute can provide neuroprotection when implanted at the site of a spinal cord injury -- preventing further damage.

20 Mar 2021

N-terminal domain antibodies play a key role in COVID immunity

Scientists are learning that a lesser-studied region on the pandemic coronavirus is recognized by COVID-19 infection-fighting antibodies. These antibodies were identified in blood samples from previously infected patients, and were found to potently prevent the virus from infecting cells.

19 Mar 2021

Study reveals unknown immune defense system that protects the lungs from viral infections

Researchers have uncovered a previously unknown arm of the immune defence system that protects the lung from lethal viral infections.

18 Mar 2021

Scientists identify address codes in odorant receptor proteins

A team of scientists led by Dietmar Krautwurst from the Leibniz Institute for Food Systems Biology at the Technical University of Munich has now identified address codes in odorant receptor proteins for the first time.

17 Mar 2021

INTEGRA’s VOYAGER adjustable tip spacing pipettes streamline the production of venom-based screening assays

Venomtech® – a leading UK-based biotechnology company founded in 2010 – is harnessing the power of natural venoms produced by animals to generate compound libraries that are used in drug discovery studies.

From INTEGRA Biosciences 17 Mar 2021

INTEGRA’s electronic pipettes eliminate user fatigue and improve pipetting productivity

CDI Labs – a biotechnology company based in Puerto Rico – is using INTEGRA’s VIAFLO and VOYAGER electronic pipettes to streamline workflows and improve accuracy for the development of next generation proteomics products.

From INTEGRA Biosciences 17 Mar 2021

48Hour Discovery and Merck join hands to accelerate drug development

48Hour Discovery and CQDM are proud to announced that the company has been awarded $800,000 for peptide drug discovery using its patented drug discovery platform.

15 Mar 2021

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

A recent study, currently available on the bioRxiv preprint server, indicates that a pair of dual-action monoclonal antibodies derived from an original 2003 SARS survivors could play an important role in the fight against coronavirus disease 2019 (COVID-19) due to their broadly neutralizing activity and the engagement of the immune system via effector function capabilities.

14 Mar 2021

Le Bonheur and UTHSC sign agreement to obtain genetic information from 25,000 DNA samples

As research into genetic causes of disease began to grow, Le Bonheur Pediatrician-in- Chief Jon McCullers, MD, knew it was time to start building a pediatric DNA biorepository.

13 Mar 2021

New book explains concept and knowledge maps about biochemical compounds

Mind Maps in Biochemistry presents a series of concept and knowledge maps about biochemical compounds, systems and techniques.

12 Mar 2021

Tiny antibodies naturally generated by llamas can be effective against COVID-19

As the fight against COVID-19 continues, scientists have turned to an unlikely source for a potentially effective treatment: tiny antibodies naturally generated by llamas.

10 Mar 2021

Researchers report zoonotic spillover of adapted SARS-CoV-2 from minks to humans

In a recent report made available on bioRxiv* preprint server, researchers from Poland and Finland reveal a spillover event of mink-adapted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from farmed mink to humans after an extensive adaptation process.

9 Mar 2021

Researchers present fragment-based computational design of antibodies that target structured epitopes

A new study describes a novel fragment-based method to design antibody complementarity determining region (CDR) loops.

8 Mar 2021

New technology may lead to 3D-printed tissues and organs

It looks like science fiction: A machine dips into a shallow vat of translucent yellow goo and pulls out what becomes a life-sized hand.

8 Mar 2021

Study: Monoclonal antibody 'cocktail' effective against all known COVID-19 variants

A monoclonal antibody "cocktail" developed at Vanderbilt University Medical Center (VUMC) to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published in the journal Nature Medicine.

5 Mar 2021

ACTIV-3 clinical trial evaluating investigational COVID-19 therapies closes enrollment in two sub-studies

The ACTIV-3 clinical trial, which is evaluating the safety and efficacy of investigational therapeutics for COVID-19 in hospitalized patients, has closed enrollment in two sub-studies: one examining the investigational monoclonal antibody therapy VIR-7831, and another evaluating the investigational combination monoclonal antibody therapy containing BRII-196 and BRII-198.

5 Mar 2021

Researchers decipher how interspecies interactions arise, evolve and are maintained

Interspecies interactions are the foundation of ecosystems, from soil to ocean to the human gut. Among the many different types of interactions, syntrophy is a particularly important and mutually beneficial interspecies interaction where one partner provides a chemical or nutrient that is consumed by the other in exchange for a reward.

5 Mar 2021

New mRNA treatment appears to stop replication of flu and Covid-19 viruses

With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes Covid-19.

4 Mar 2021

Biotechnology News and Research

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

New book explains the functional aspects of melanogenesis and related disorders

Novel form of polymerized estrogen could provide neuroprotection

N-terminal domain antibodies play a key role in COVID immunity

Study reveals unknown immune defense system that protects the lungs from viral infections

Scientists identify address codes in odorant receptor proteins

INTEGRA’s VOYAGER adjustable tip spacing pipettes streamline the production of venom-based screening assays

INTEGRA’s electronic pipettes eliminate user fatigue and improve pipetting productivity

48Hour Discovery and Merck join hands to accelerate drug development

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

Le Bonheur and UTHSC sign agreement to obtain genetic information from 25,000 DNA samples

New book explains concept and knowledge maps about biochemical compounds

Tiny antibodies naturally generated by llamas can be effective against COVID-19

Researchers report zoonotic spillover of adapted SARS-CoV-2 from minks to humans

Researchers present fragment-based computational design of antibodies that target structured epitopes

New technology may lead to 3D-printed tissues and organs

Study: Monoclonal antibody 'cocktail' effective against all known COVID-19 variants

ACTIV-3 clinical trial evaluating investigational COVID-19 therapies closes enrollment in two sub-studies

Researchers decipher how interspecies interactions arise, evolve and are maintained

New mRNA treatment appears to stop replication of flu and Covid-19 viruses

Event guide: 3rd IMPACCT Real World Evidence Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News